Violeta Mihaylova-Bakardjieva

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Parallel Liquid Biopsy Analysis of miR-371a-3p and Cell-Free DNA in an Unselected Cohort of Patients With Testicular Germ Cell Tumors.

Parallel Liquid Biopsy Analysis of miR-371a-3p and Cell-Free DNA in an Unselected Cohort of Patients With Testicular Germ Cell Tumors.

Journal: Andrology

Published: October 31, 2025

CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors.

CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors.

Journal: European journal of immunology

Published: June 17, 2025

The clinical value of circulating free tumor DNA in testicular germ cell tumor patients.

The clinical value of circulating free tumor DNA in testicular germ cell tumor patients.

Journal: Urologic oncology

Published: December 04, 2021

A homozygous deletion in the SLC19A1 gene as a cause of folate-dependent recurrent megaloblastic anemia.

A homozygous deletion in the SLC19A1 gene as a cause of folate-dependent recurrent megaloblastic anemia.

Journal: Blood

Published: April 11, 2020

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors.

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors.

Journal: Cancers

Published: June 10, 2019

Molecular Pathogenesis of Testicular Germ Cell Tumors

Molecular Pathogenesis of Testicular Germ Cell Tumors

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: December 23, 2017

Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.

Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.

Journal: Cancer letters

Published: December 22, 2015

The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL.

The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL.

Journal: Blood

Published: August 22, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026